{"DataElement":{"publicId":"6479327","version":"1","preferredName":"Merkel Cell Cancer AJCC Edition 8 Clinical Group Stage","preferredDefinition":"Clinical stage group based on the combination of T, N, and M categories and relevant prognostic factors for merkel cell carcinoma, using AJCC Ed. 8 criteria.","longName":"MCC_AJC8_CLN_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6477697","version":"1","preferredName":"Merkel Cell Neoplasm Clinical Stage Grouping","preferredDefinition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"6477683v1.0:2925061v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6477683","version":"1","preferredName":"Merkel Cell Neoplasm","preferredDefinition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12592:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell","conceptCode":"C12592","definition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E3EF07-8EE9-4141-E053-F662850A90EE","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2925061","version":"1","preferredName":"Clinical Stage Grouping","preferredDefinition":"Having to do with the examination and treatment of patients.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25398:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FD8E36A-281E-6D78-E040-BB89AD43144A","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"77E5FFC4-3FAD-06C7-E053-F662850A7C56","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-10-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6479280","version":"1","preferredName":"Merkel Cell Carcinoma American Joint Committee on Cancer Edition 8 Clinical Group Stage","preferredDefinition":"A term that refers to the clinical staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6479280v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Clinical Stage IV Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479282","version":"1","preferredName":"Clinical Stage IV Merkel Cell Carcinoma AJCC v8","longName":"6479282","preferredDefinition":"Stage IV includes: T0-4, Any N, M1. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. M1: Distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136878","definition":"Stage IV includes: T0-4, Any N, M1. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. M1: Distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6C914-3B50-078D-E053-F662850A5839","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6C914-3B69-078D-E053-F662850A5839","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"III","valueDescription":"Clinical Stage III Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479284","version":"1","preferredName":"Clinical Stage III Merkel Cell Carcinoma AJCC v8","longName":"6479284","preferredDefinition":"Stage III includes: T0-4, N1-3, M0. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1: Metastasis in regional lymph node(s). N2: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. N3: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136877","definition":"Stage III includes: T0-4, N1-3, M0. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1: Metastasis in regional lymph node(s). N2: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. N3: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6C914-3B76-078D-E053-F662850A5839","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6C914-3B8F-078D-E053-F662850A5839","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Clinical Stage IIB Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479286","version":"1","preferredName":"Clinical Stage IIB Merkel Cell Carcinoma AJCC v8","longName":"6479286","preferredDefinition":"Stage IIB includes: T4, N0, M0. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136876","definition":"Stage IIB includes: T4, N0, M0. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6C914-3B9C-078D-E053-F662850A5839","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6C914-3BB5-078D-E053-F662850A5839","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Clinical Stage IIA Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479288","version":"1","preferredName":"Clinical Stage IIA Merkel Cell Carcinoma AJCC v8","longName":"6479288","preferredDefinition":"Stage IIA includes: T2-3, N0, M0. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136875","definition":"Stage IIA includes: T2-3, N0, M0. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6C914-3BC2-078D-E053-F662850A5839","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6C914-3BDB-078D-E053-F662850A5839","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"I","valueDescription":"Clinical Stage I Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479290","version":"1","preferredName":"Clinical Stage I Merkel Cell Carcinoma AJCC v8","longName":"6479290","preferredDefinition":"Stage I includes: T1, N0, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage I Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136873","definition":"Stage I includes: T1, N0, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6C914-3BE8-078D-E053-F662850A5839","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6C914-3C01-078D-E053-F662850A5839","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"0","valueDescription":"Clinical Stage 0 Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479292","version":"1","preferredName":"Clinical Stage 0 Merkel Cell Carcinoma AJCC v8","longName":"6479292","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: In situ primary tumor. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136872","definition":"Stage 0 includes: Tis, N0, M0. Tis: In situ primary tumor. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6C914-3C0E-078D-E053-F662850A5839","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6C914-3C27-078D-E053-F662850A5839","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6479279","version":"1","preferredName":"Merkel Cell Carcinoma by AJCC v8 Clinical Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the clinical staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C136871:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Merkel Cell Carcinoma by AJCC v8 Clinical Stage","conceptCode":"C136871","definition":"A term that refers to the clinical staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6C914-3B23-078D-E053-F662850A5839","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"77F6C914-3B34-078D-E053-F662850A5839","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-11-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6477698","version":"1","longName":"Merkel Cell","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical disease stage","type":"Preferred Question Text","description":"Clinical disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"77F74F02-F605-6407-E053-F662850A6FC5","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-11-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}